Serving patients across Europe and Middle East, as owner and CEO, Prof. Ehninger has grown the company without outside investors to an end-to-end cell therapy manufacturer, and Cellex is a growing ...
Nurses who are administering HTS to patients need to exercise vigilance ... concern with the use of hyperosmolar therapies for TBI. Renal problems can be minimized by maintaining euvolemia.